Targeting CCR4 with mogamulizumab in refractory CD3 - CD4 + lymphocytic-variant hypereosinophilic syndrome

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 109; no. 6; pp. 1984 - 1988
Main Authors Ledoult, Emmanuel, Groh, Matthieu, Meresse, Bertrand, Dubois, Romain, Trauet, Jacques, Toussaint, Elise, Delbeke, Marie, Hachulla, Eric, Terriou, Louis, De Masson, Adèle, Vasseur, Michele, Labalette, Myriam, Launay, David, Kahn, Jean-Emmanuel, Lefevre, Guillaume
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.06.2024
SeriesHaematologica
Subjects
Aged
Antibodies, Monoclonal, Humanized - administration & dosage
Antibodies, Monoclonal, Humanized - therapeutic use
CD3 Complex
CD4 Antigens - metabolism
CD4-Positive T-Lymphocytes - drug effects
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - metabolism
Female
Humans
Hypereosinophilic Syndrome - diagnosis
Hypereosinophilic Syndrome - drug therapy
Hypereosinophilic Syndrome - pathology
Life Sciences
Male
Middle Aged
Receptors, CCR4 - antagonists & inhibitors
Receptors, CCR4 - metabolism
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
PMCID: PMC11141653
ISSN:0390-6078
1592-8721
1592-8721
DOI:10.3324/haematol.2023.284429